Patent Yard Sign in
Expired European patentEurope

Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response

EP 1183022 B1 · Applicant: Cellular Sciences, Inc.

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed April 14, 2000 and granted December 29, 2010. A European patent lasts at most 20 years from filing, so its term ended April 14, 2020.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by October 14, 2025.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledApril 14, 2000
PublishedMarch 6, 2002
GrantedDecember 29, 2010
Term endedApril 14, 2020
Application numberEP 00925997
Classification (CPC)A61P43/00 +2 more

Timeline

Timeline From EPO dates

2001200320052007200920112013201520172019Application filedApril 14, 2000PublishedMarch 6, 2002Patent grantedDec 29, 2010Term endedApril 14, 2020

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.